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Abstract
Background: The Coloboma mouse carries a ,2 cM deletion encompassing the SNAP25 gene and has a hyperactive
phenotype similar to that of ADHD. Such mice are 3 fold more active compared to their control littermates. Genetic
association studies support a role for allelic variants of the human SNAP25 gene in predisposing to ADHD.
Methods/Principal Findings: We performed association analysis across the SNAP25 gene in 1,107 individuals (339 ADHD
trios). To assess the functional relevance of the SNAP25-ADHD associated allele, we performed quantitative PCR on post-
mortem tissue derived from the inferior frontal gyrus of 89 unaffected adults. Significant associations with the A allele of
SNP rs362990 (x2 = 10, p-corrected = 0.019, OR = 1.5) and three marker haplotypes (rs6108461, rs362990 and rs362998) were
observed. Furthermore, a significant additive decrease in the expression of the SNAP25 transcript as a function of the risk
allele was also observed. This effect was detected at the haplotype level, where increasing copies of the ADHD-associated
haplotype reduced the expression of the transcript.
Conclusions: Our data show that DNA variation at SNAP25 confers risk to ADHD and reduces the expression of the transcript
in a region of the brain that is critical for the regulation of attention and inhibition.
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Introduction
Attention deficit hyperactivity disorder (ADHD) is a highly
heritable disorder of childhood with significant functional impair-
ment and negative lifetime outcomes across all developmental
stages. The disorder is marked by disruption of catecholamine
signaling, with mainstay treatments for the disorder targeting the
dopamine and noradrenaline transporters and the alpha 2a
adrenoreceptor [1]. Although a focus on these molecular targets
has proven informative for genetic association, identifying the
molecular machinery driving neurotransmitter release may
provide critical insights into the biology of ADHD.
Synaptosomal-associated protein (SNAP-25) is a presynaptic
plasma membrane protein that is specifically and highly expressed
in nerve cells. The gene encodes a protein component, which
interacts with the membrane associated protein syntaxin, and
vesicle-associated membrane protein (VAMP) to form the SNARE
complex. This complex interacts with membrane proteins known
as synaptotagmin to make up a core complex essential for docking
and holding synaptic vesicles at the presynaptic membrane in
preparation for Ca2+-triggered neurotransmitter exocytosis [2].
The Coloboma mouse bears a semi-dominant mutation (cm/+)
in which the heterozygous form results in the mutant type while
the homozygous is lethal. The mutation is a ,2 Cm deletion
encompassing genes including SNAP25 and the gene encoding
phospholipase C beta (PLCB-1) [3,4], mapping to human
chromosome 20 [5]. The Coloboma mouse is considered an
animal model of ADHD as it displays a hyperactive phenotype
that is reduced by stimulant drugs such as dextroamphetmaine [6].
An increase of up to 40% in noradrenaline within the striatum and
the nucleus accumbens of the Coloboma mouse has been reported
[7]. Furthermore, mRNA expression of Tyrosine Hydroxylase (a
rate limiting enzyme in the synthesis of dopamine and noradren-
aline) was significantly increased in the cells of the noradrenergic
locus coeruleus, indicating that a perturbed level of noradrenaline
(presumably caused by the lack of SNAP25 copy) may contribute to
the hyperactive behavior of the coloboma. Similarly, NA depletion
using DSP-4(N-(2-chloroethyl)-N-ethyl-2 bromobenzylamine hy-
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drochloride) significantly reduced hyperactivity in the Coloboma
mouse, supporting the noradrenaline hypothesis [8].
Genetic association studies suggest that allelic variations in the
SNAP25 gene might confer susceptibility to ADHD. An initial
analysis [9] on two single nucleotide polymorphisms (SNPs)
(rs3746544 and rs1051312) located at the 39untranslated (39UTR)
region of the gene found a trend toward excess transmission of the
C allele of rs1051312. Significant association of the above 2-SNP
haplotype was reported [10,11]. Brophy et al. [11] reported
preferential transmission of allele T of rs1051312 to Irish ADHD
cases. Two other studies have shown association with ADHD
using a microsatellite marker in intron 1 and marker rs363006
mapped to intron 7 of the gene [12,13]. Other SNPs within the
gene have also been reported to associate with ADHD in more
recent studies. Feng et al. [14] observed association with SNPs
rs6039806, rs362549, rs362987 and rs362988, mapped to introns
3, 4, 5 and 7 respectively, while Kim et al. [15] reported
association with SNP rs3787283 (intron 7), which is in strong
linkage disequilibrium (LD) with the 39UTR SNPs rs3746544 and
rs1051312 (D9=0.89–0.94). Association with rs3746544 has also
been reported in Korean [16] and Eastern Indian ADHD samples
(17]. Other studies however failed to observe significant associa-
tion between SNAP-25 variants and ADHD [18,19]. A recent
meta-analysis demonstrates that there is considerable evidence to
support an association between ADHD and DNA variation in the
SNAP25 gene [20]. Together, these findings provide promising
evidence that SNAP-25 is likely to contribute to the development
of ADHD and that the region between intron 3 and the 39UTR
may contain a variant(s) affecting gene’s expression.
Here we sought to provide additional evidence for a role of
SNAP-25 in ADHD by performing dense SNP mapping across the
gene in nuclear families with ADHD. To assess the functional
relevance of ADHD-associated variants, we performed quantita-
tive PCR (qPCR) of the SNAP-25 transcript in a large sample
(N= 89) of post-mortem brains from non-clinical individuals. Our
qPCR work focused on expression of the transcript in human
inferior frontal gyrus (IFG), an area of the cortex that has
consistently been implicated in ADHD from both structural and
functional imaging analyses [21,22]. We show that ADHD-
associated variants of SNAP25 influence expression within the IFG,
with decreased SNAP-25 expression (as expected from the
Coloboma mouse) associated with the ADHD risk variants.
Materials and Methods
ADHD participants
A total sample of 1,017 individuals, comprising 339 Caucasian
ADHD probands and their parents (full trios) across three similar
sub-samples was investigated. The first cohort comprised 185 full
trios recruited throughout Ireland from child psychiatric clinics
and schools in West County Dublin and from the Hyperactive and
Attention Deficit Children’s Support Group of Ireland. Consensus
diagnoses were made according to DSM-IV ADHD either with or
without comorbidity. These diagnoses were based on all available
clinical information and the Child Behaviour Checklist (CBCL),
the Conners’ Parents and Teachers Rating Scales, and the
Comprehensive Teachers Rating Scale (ACTeRS) [23]. The
second sample comprised 68 Australian nuclear families with
ADHD recruited from the Royal Children’s Hospital Melbourne
and the Queensland Brain Institute, Brisbane. This sample shared
diagnostic, inclusion and exclusion criteria with the Irish sample
[24]. The third sample was ascertained from several child
psychiatric clinics in the United Kingdom. It comprised 86 trios
where the child met DSM-IV diagnostic criteria for ADHD, as
assessed using the same instruments as for the Irish cases [25].
Across all three cohorts, the mean age of the participants was
10.53 years (SD=3.67) and were predominantly male (87%). All
probands fulfilled DSM-IV diagnostic criteria for ADHD. Of
these, N=44 (13%) had the inattentive subtype, and N=19 (5.6%)
had the hyperactive impulsive subtype; the remainder had the
combined subtype (81.4%). One hundred and seventy-nine
probands (52.8%) had a comorbid diagnosis of oppositional
defiant disorder (ODD) and 34 (10%) fulfilled criteria for
comorbid conduct disorder (CD). Frequencies of ADHD subtypes
Table 1. TDT analysis of SNAP25 polymorphisms in ADHD nuclear families.
SNP Allele T NT x2 p-value Ep-value* OR SNP position
rs3787303 T 74 73 0.007 0.9343 1.0 1.01 intron 1
rs363012 A 132 128 0.062 0.8041 1.0 1.03 intron 1
rs363039 G 153 151 0.013 0.9087 1.0 1.01 intron 1
rs12626080 G 148 145 0.031 0.8609 1.0 1.02 intron 1
rs363052 G 100 97 0.046 0.8307 1.0 1.03 intron 1
rs363020 T 75 66 0.574 0.4485 0.99 1.13 intron 1
rs362562 G 172 138 3.72 0.0535 0.41 1.25 intron 1
rs6108461 A 186 136 7.764 0.0053 0.06 1.37 intron 3
rs362990 A 150 100 10 0.0016 0.02 1.5 intron 4
rs362998 C 40 32 0.889 0.3458 0.99 1.25 exon 6
rs6039820 C 152 136 0.889 0.3458 1.0 1.11 intron 6
rs6108464 T 165 159 0.111 0.7389 1.0 1.04 intron 6
rs3787283 A 146 136 0.355 0.5515 1.0 1.07 intron 6
rs3746544 C 162 143 1.184 0.2766 0.97 1.13 39UTR
rs8636 T 174 149 1.935 0.1642 0.86 1.18 39UTR
T= Transmitted, NT = Not Transmitted, * = Empirical P-value from HAPLOVIEW assessed the gene-wide significance value estimated on the basis of 10000
permutations.
doi:10.1371/journal.pone.0060274.t001
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and comorbidities were similar across the recruitment sites. We
obtained a written consent from the next of kin, caretakers, or
guardians on the behalf of the minors/children participants
involved in our study. The consent was in accordance with the
declaration of Helsinki and the ethical approvals from the
University of Queensland, Australia, Trinity College Dublin,
Ireland, and the University of Birmingham, UK’’
Non-pathological brain samples
In addition to the ADHD samples, 89 unaffected Caucasian
brain samples (inferior frontal gyrus; IFG) were obtained from the
Australian Brain Bank. Of these, 63 (71%) were from male
subjects. None of these individuals were diagnosed with ADHD or
other psychiatric condition. The mean age of the sample was
51.6 years (SD=12.2), PH ranged from 5.8–7 and the post-
mortem interval (PMI) was 28.2 hours (SD=14).
SNP selection and genotyping
Fifteen SNPs were included in the current investigation
(Table 1). SNPs were selected using Haploview default SNP
tagging criteria. In addition, some SNPs that had been implicated
in ADHD from previous studies (rs363020, rs3746544 and rs8636)
were also included. Genotyping was commercially performed at
the Australian Genome Research Facility (AGRF) using iPLEX
Figure 1. Linkage disequilibrium relation (expressed as D9 values) of snap25 examined SNPs.
doi:10.1371/journal.pone.0060274.g001
Table 2. Haplotype analysis of SNAP25 SNPs in ADHD nuclear
families.
Haplotype Freq. T UT x2 p value
Empirical p
value*
Block 1
AG 0.455 168 145 1.681 0.1947 0.865
AA 0.411 146 180 3.602 0.0577 0.317
TG 0.135 82 70 0.842 0.359 0.953
Block 2
AAC 0.543 193 140 8.372 0.0038 0.0198
GTC 0.258 104 160 11.99 5.00E204 0.0019
GAC 0.139 87 80 0.597 0.4395 0.986
GAT 0.056 33 40 0.78 0.3771 0.961
Block 3
AC 0.624 151 169 1.002 0.3169 0.94
CT 0.358 172 149 1.682 0.1947 0.865
Freq = Haplotype frequency, T = Transmitted, UT = Untransmitted, * = 10000
permutation.
doi:10.1371/journal.pone.0060274.t002
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GOLD chemistry with a Sequenom MassArray on an Autoflex
Spectrometer (Sequenom, San Diego, CA). The genotyping
success rate for all SNPs ranged between 96.7–98.9%. Genotyping
of SNAP-25 SNPs rs362562 and rs362990 of the non-clinical
brain samples was conducted using TaqMan assays C_11682_10
and C_2488333_10 respectively. SNP rs6108461 was genotyped
using a standard PCR-RFLP assay. This was conducted using the
forward primer 59 CTTGAAGCATCCCAGGAAGA and the
reverse 59 GAAGGAAAAATGTTGGGGTTT 39. The PCR
product (214 bp) was then restricted with the enzyme Cac81 and
the DNA fragments were fractionated on a 3% agarose gel. The G
allele was characterized by 164 bp and 51 bp fragments while the
A allele was characterized by 215 bp fragment.
qPCR and SNAP-25 expression
Approximately 100–200 mg of inferior frontal gyrus (IFG) tissue
of each sample was used to extract RNA and DNA using TRIZOL
reagent as recommended by the manufacturers (Invitrogen). As
PH is considered a good indicator of RNA purity and integrity,
this was measured and found to range from 5.8–7. The optical
density (OD) at 260/280 of RNA preparations ranged from 2–2.1
indicating good quality of the RNA preparation.
Figure 2. Relative expression of SNAP25 in non- pathological samples. A and B show decreased expression with ADHD associated alleles; C
and D show the level of expression relative to ADHD risk and protective haplotypes respectively. Error bars represent the standard error of the mean.
doi:10.1371/journal.pone.0060274.g002
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To minimize RNA contamination with the DNA, samples were
treated with DNASE-I and cleaned using RNeasy Mini Kit as
recommended by manufacturers (Qiagen, Doncaster, Victoria,
Australia). Furthermore, to prevent any possible interference by
DNA contamination when conducting qPCR, the target (SNAP25)
and the reference genes b2micoglobulin (b2M) and beta actin
Table 3. Linkage disequilibrium relation of previously associated ADHD-SNAP25 variants with SNPs of this investigation.
Previous Study
Associated
SNPS position
Current
investigation D9 r2
Barr et al. [9]; Kustanovich rs3746544 39UTR rs6108461 0.40 0.11
et al. [10] and Brophy et al. [11] rs1051312 39UTR rs6108461 ND ND
Mill et al. [13] rs363006 Intron 7 rs6108461 1.0 0.27
Feng et al. [14] rs6039806 Intron 3 rs6108461 1.00 1.00
rs362549 Intron 4 rs6108461 1.00 1.00
rs362987 Intron 5 rs6108461 1.00 1.00
rs362988 intron 7 rs6108461 1.00 0.10
Brookes et al. [35] rs363020 Intron 1 rs6108461 1.00 0.18
Kim et al. [15] rs3787283 Intron 7 rs6108461 0.19 0.01
Guan et al. [36] rs8636 39UTR rs6108461 0.40 0.11
Elia et al. [19] rs363032 Intron 1 rs6108461 0.26 0.04
rs6133852 Downstream rs6108461 1.00 0.05
Mick et al. [31] rs362562 Intron 1 rs6108461 0.91 0.74
rs362569 Intron 1 rs6108461 0.92 0.78
rs362564 Intron 1 rs6108461 0.93 0.37
Sarkar et al. [17] rs362569 Intron 1 rs6108461 0.92 0.78
rs362988 Intron 7 rs6108461 0.54 0.20
Lasky-Su et al. [30] rs363012 Intron 1 rs6108461 0.58 0.09
rs363043 Intron 1 rs6108461 0.8 0.31
rs362547 Intron 1 rs6108461 0.92 0.79
rs1984830 Down stream rs6108461 0.20 0.016
rs6032846 Down stream rs6108461 0.018 0.0
Barr et al. [9]; Kustanovich rs3746544 39UTR rs362990 0.63 0.08
et al. [10] and Brophy et al. [11] rs1051312 39UTR rs362990 ND ND
Mill et al. [13] rs363006 Intron 7 rs362990 1.00 0.06
Feng et al. [14] rs6039806 Intron 3 rs362990 1.00 0.27
rs362549 Intron 4 rs362990 1.00 0.27
rs362987 Intron 5 rs362990 1.00 0.27
rs362988 Intron 7 rs362990 0.51 0.11
Brookes et al. [35] rs363020 Intron 1 rs362990 1.00 0.04
Kim et al. [15] rs3787283 Intron 7 rs362990 0.39 0.09
Guan et al. [36] rs8636 39UTR rs362990 0.63 0.08
Elia et al. [19] rs363032 Intron 1 rs362990 0.01 0.00
rs6133852 Downstream rs362990 0.31 0.01
Mick et al. [31] rs362562 Intron 1 rs362990 0.89 0.25
rs362569 Intron 1 rs362990 1.00 0.30
rs362564 Intron 1 rs362990 1.00 0.12
Sarkar et al. [17] rs362569 Intron 1 rs362990 1.00 0.30
rs362988 Intron 7 rs362990 0.51 0.11
Lasky-Su et al. [30] rs363012 Intron 1 rs362990 0.49 0.017
rs363043 Intron 1 rs362990 0.04 0.001
rs362547 Intron 1 rs362990 1.00 0.30
rs1984830 Downstream rs362990 0.43 0.023
rs6032846 Down stream rs362990 0.27 0.14
ND= LD Not defined.
doi:10.1371/journal.pone.0060274.t003
DNA Variations in SNAP25 Gene Confer Risk to ADHD
PLOS ONE | www.plosone.org 5 April 2013 | Volume 8 | Issue 4 | e60274
(ACTB) gene primers were designed to amplify DNA regions
involving exon 7 and 8 of SNAP25, exons 1 and 2 in b2M and exon
3 and 4 of ACTB. The qPCR primers were designed using the
INTEGRATED DNA TECHNOLOGIES Oligo Design Tool,
which is freely available at http://www.idtdna.com/scitools/
scitools.aspx. The SNAP-25-qPCR forward primer sequence was
59ATGGATGAAAACCTAGAGCAGG 39 and the reverse was
59ACACTTAAC CACTTCCCAGC 39. The b2M forward
primer sequence was 59 GGCATTCCTG AAGCTGACAG 39
whereas the reverse was 59TGGATGAAACCCAGACACATAG
39. The ACTB qPCR forward primer was 59ACCACACCTTC-
TACAATGAGC 39 and the reverse was 59 GCGTACAGGGA-
TAGCACAG39. In this context, b2M and ACTB were used as
reference genes as they have stable gene expression in various
tissues including brain. A standard Invitrogen procedure was used
to synthesize first cDNA strands of the samples. Relative
quantification was performed using SNAP25 (target gene) com-
pared to b2M and ACTB (reference genes). PCR cycling was
performed on a Roche LightCycler-480. Cycling conditions were
95uC for 5 min followed by 45 cycles at 95uC for 10 sec, 60uC for
10 sec and 72uC for 20 sec. This was followed by a melting curve
cycle at 95uC for 5 sec and 1 min at 65uC. mRNA relative was
expression quantified using normalized threshold cycles (Ct) of
target relative to reference genes.
Statistical analysis
Assessment of Hardy Weinberg Equilibrium for all SNPs was
undertaken using parental DNA of the ADHD participants. All
genotypes were in Hardy Weinberg equilibrium. Genetic associ-
ation across a 15 SNP array was performed using the transmission
disequilibrium test (TDT). Haplotype analysis to test for the
transmission of multi locus haplotypes was performed by applying
the default block definition in HAPLOVIEW (http://www.broad.
mit.edu/mpg/haploview) using the method of Gabriel et al. [26].
A SNP block is formed if 95% of informative comparisons are in
strong LD. Associations between ADHD risk variants and SNAP-
25 expression in post-mortem IFG tissue was tested using linear
regressions with an additive model (0 vs. 1 vs. 2 copies of the risk
variant). In addition, possession (0 vs. 1 vs. 2 copies) of the risk or
protective haplotypes was also assessed using linear regression.
Results
Genetic association
Fifteen SNPs were examined at the SNAP25 gene covering a
region of 88,6 kbp. TDT analyses of all individual SNPs are
presented in Table 1. Two SNPs rs6108461 and rs362990, showed
significant nominal association with ADHD (rs6108461: x2 = 7.76,
p = 0.0053, OR=1.37; and rs362990: x2 = 10, p = 0.0016,
OR=1.5). Permutation testing (10,000 permutations) revealed
that only rs362990 (x2 = 10, p-corrected = 0.019, OR=1.5) was
associated with ADHD, with a trend towards association for
rs6108461 (p-corrected = 0.059).
Although strong LD is apparent across the gene (Figure 1), three
distinct blocks of LD were evident, with SNPs rs363020 and
rs362562 form the first block and SNPs rs6108461, rs362990,
rs362998 forming the second. The third block comprises the SNPs
rs3746544 and rs8636. Haplotype analysis (Table 2) within these
blocks showed significant association of a predisposing haplotype
made of alleles AAC of the second block (x2 = 8.37, p-corrected
= 0.019, OR=1.4). An exploratory haplotype analysis using
sliding window of 8 SNPs (,20 kbp) extending from intron 3
(rs6108461) to the 3UTR (rs8636) enhanced the risk association
signal (x2 = 12.7, p= 0.0004, p-corrected = 0.003, OR=1.62).
Finally, a haplotype comprised of the alleles GTC in the second
haplotype block (see Figure 1) was less transmitted to ADHD cases
than expected by chance (x2 = 11.99, p-corrected = 0.0019,
OR=0. 65). This implies that this haplotype may confer
protection against the development of ADHD.
Functional analysis (qPCR)
A significant association between rs362990 and relative
expression of the SNAP-25 transcript was observed (Figure 2).
Specifically, increasing copies of the ADHD-associated A allele
were associated with decreased SNAP-25 expression [F(1,84)
= 5.5, p = 0.02; R2 change = 5.6.2%]. Similar results were found
for rs6108461 [F(1,84) = 8.9, p = 0.004; R2 change = 8.7%]. The
strong LD between these SNPs meant that controlling for one
removed the effect of the other in the above analyses. Possession of
the ADHD risk haplotype (AAC) was also significantly associated
with expression of SNAP-25 in the IFG tissue [Figure 2C; F(1,84)
= 6.3, p = 0.01; R2 change = 6.3%]. As expected, increasing
possession (0 vs. 1 vs. 2 copies) of the risk haplotype was associated
with decreased expression. Conversely, increasing possession of the
protective haplotype was associated with increased SNAP-25
expression [Figure 2D; F(1,84) = 7.8, p = 0.007 R2
change= 7.7%].
Discussion
The results of the current study show that DNA variants of the
SNAP25 gene that associate with ADHD are also associated with
functional changes in the expression level of the transcript in a
region of the brain that is an established pathological locus for
ADHD. The current investigation provides further support for the
notion that SNAP25 is a genetic risk factor for ADHD. Although
nominal associations with two SNAP25 SNPs (rs6108461and
rs362990) were observed, only the association with rs362990
survived permutation testing. Haplotype analysis enhanced the
association (OR=1.62), suggesting that the region between intron
3 and the 39UTR of SNAP25 may harbor an important
susceptibility variant for ADHD.
SNAP-25 is important for axonal growth and synaptic plasticity,
which are essential steps for wiring the nervous system. Selective
inhibition of SNAP-25 expression prevents neurite elongation of
cortical neurons [27]. In addition, a high level of SNAP-25
expression in the adult brain was found to contribute to nerve
terminal plasticity [28]. Furthermore, SNAP-25 functions in
docking and fusion of synaptic vesicles in presynaptic neurons,
which are essential for the regulation of neurotransmitter release.
These functions make SNAP25 an important candidate gene for
ADHD.
Our results are consistent with some but not all previous
association/linkage studies. Apart from the current investigation, a
number of studies have tested for association between SNAP25
gene variants and ADHD. All these studies have examined
multiple SNPs and tested for association of single SNPs and
haplotypes. The associated SNPs and their position within the
SNAP25 gene are presented in Table 3. Careful inspection of the
data shows that ADHD-associated SNPs are clustered into two
main regions. The first region, supported by eight studies,
encompasses a region of 29 kbp extending from rs6039806 to
rs8636 and maps between intron 3 and the 39UTR of the gene.
The second region, supported by five studies, extends from
rs363032 to rs362569 spanning a region of 28 kbp and is mapped
to intron 1. The associated SNPs in the current study
(rs6108461and rs362990) map to introns 3 and 4. Interestingly,
there are strong LD relations between these SNPs and those
DNA Variations in SNAP25 Gene Confer Risk to ADHD
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reported to associate with ADHD (except those mapped down-
stream of SNAP25; see Table 3). Furthermore, extended haplotype
analysis comprising eight SNPs located between intron 3
(rs6108461) and the 3UTR (rs8636) enhanced the association
(x2 = 12.7, p-corrected = 0.003, OR=1.62) indicating that this
region may harbor a risk/functional variant for ADHD.
Furthermore, it is important to emphasize that the quartile–
quartile (QQ) plot for ADHD genome wide association (GWAS)
for SNPs in or near candidate genes [29] showed mild inflation in
the p-value distribution, providing evidence for association
(although not significant at GWAS level). For SNAP25, several
SNPs showed evidence of association with the symptoms of
ADHD in a quantitative GWAS [30]. Three of these SNPS
(rs363012, rs363043 and rs362547) are mapped to intron 1 of the
gene. Interestingly, rs363043 and rs362547 (associated with total
ADHD symptoms and with inattentive symptoms, respectively)
(Lasky-su; personal communication) have strong LD with the
ADHD-associated SNPs of the current study (Table 3) which
further emphasises the importance of our findings. In addition, a
recently published ADHD-GWAS reported evidence of associa-
tion with 4 SNAP25 markers including rs362562 [31]. The latter
SNP is in strong LD with our SNPs (rs6108461: D9=0.91;
rs362990: D9=0.89) and showed a trend toward association in our
sample (Table 1) further confirming the importance of SNAP25
variations in ADHD.
Computer simulation [32] suggests that the 39UTR SNPs
rs3746544 and rs1051312 (map within the associated region of this
study) may alter the binding site of microRNAs (miR-510- miR-
641) and consequently influence the level of SNAP-25 expression.
Indeed, the post-mortem work reported herein hints at a potential
pathophysiological mechanism by which SNAP25 variants may
increase risk to ADHD. Specifically, the lowered expression of
SNAP-25 in regions of the cortex that are critical for attention and
inhibition, such as the IFG, may ultimately decrease the efficiency
of neurotransmitter release and synaptic function, impairing
behavior and cognition and conferring risk to ADHD. It should
be noted however that the above hypothesis must be viewed with
some caution since the current study did not test the expression of
SNAP25 in post-mortem samples derived from individuals with
ADHD.
Recent biochemical analyses have shown that SNAP-25 amino
acids (AA) 7–83 and 141–204 are essential motifs that are
spontaneously assembled into helical SNARE complexes with
Syntaxin1 and synaptobrevin 2 motifs [33]. SNAP25 mutations
introduced to the C terminal of the protein at AA positions 78, 81
and 202 resulted in a near elimination of exocytosis [34].
Furthermore, two alternative transcripts have been observed
encoding two SNAP-25 protein isoforms. Variant 1 has 8 exons
whereas variant 2 contains an alternative exon 5 as compared to
variant 1, with the resulting isoform being of the same length but
differing by 9 amino acids. Although we do not know which
SNAP-25 isoforms are associated with ADHD, it is important to
note that the SNAP-25 motif (AA 7–83 and 141–204) that is
critical to SNARE formation and the exon 5 splice variant
described above, all lie within the ADHD-associated region
described herein. These observations further emphasize the
importance of this region for the integrity of SNAP-25 and
SNARE function and consequently for the development of
ADHD.
In summary, this study provides support for the involvement of
SNAP25 as a susceptibility locus for ADHD. We hypothesize that
the region between intron 3 and the 3UTR of SNAP25may harbor
functional variants that confer risk to ADHD. Finally, we stress the
importance of independent replication of our findings preferably
in different ethnic samples.
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